World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
106
Citations
39753
World Ranking
567
National Ranking
338

Medicine

D-Index
106
Citations
41364
World Ranking
6539
National Ranking
3472

Harry L. Malech publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Harry L. Malech sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 510 publications — 90th percentile

90% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Harry L. Malech D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Harry L. Malech sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 106 D-Index — 89th percentile

89% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Harry L. Malech is affiliated with the National Institutes of Health in the United States. Their research spans multiple fields with a strong emphasis on Medicine, Biochemistry, Genetics and Molecular Biology, and Immunology and Microbiology. Within these areas, specific subfields of study include Immunology, Genetics, Molecular Biology, Oncology, and Epidemiology.

The scientist's work covers a diverse range of topics, reflecting a focus on cellular and molecular mechanisms related to immune function and genetic therapies. Key topics of their research include:

  • Neutrophil, Myeloperoxidase and Oxidative Mechanisms
  • Virus-based gene therapy research
  • CAR-T cell therapy research
  • Immunodeficiency and Autoimmune Disorders
  • CRISPR and Genetic Engineering
  • Immune Cell Function and Interaction
  • Cytomegalovirus and herpesvirus research

Recent publications highlight work in gene therapy and immunology, including studies on genetic treatment approaches and cellular differentiation tools. Notable recent papers include:

  • Lentiviral gene therapy for X-linked chronic granulomatous disease, 2020, Nature Medicine
  • Autologous Ex Vivo Lentiviral Gene Therapy for Adenosine Deaminase Deficiency, 2021, New England Journal of Medicine
  • Artificial thymic organoids represent a reliable tool to study T-cell differentiation in patients with severe T-cell lymphopenia, 2020, Blood Advances
  • Enhanced homology-directed repair for highly efficient gene editing in hematopoietic stem/progenitor cells, 2021, Blood
  • Lentiviral Gene Therapy for Artemis-Deficient SCID, 2022, New England Journal of Medicine

Frequent collaborators in Malech's research include:

  • Suk See De Ravin
  • Elizabeth M. Kang
  • Steven M. Holland
  • Luigi D. Notarangelo
  • Christa S. Zerbe

Prominent publication venues where Malech's research frequently appears are:

  • Blood
  • Journal of Clinical Immunology
  • Transplantation and Cellular Therapy
  • Journal of Allergy and Clinical Immunology
  • New England Journal of Medicine

Their body of work includes nearly a hundred publications in Medicine, complemented by extensive work in related biomedical sciences. Recognition in their professional community includes membership in the Association of American Physicians.

Best Publications

  • Chronic granulomatous disease. Report on a national registry of 368 patients.

    Jerry A. Winkelstein;Mary C. Marino;Richard B. Johnston;John Boyle

  • Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease

    Christian Lood;Luz P Blanco;Monica M Purmalek;Carmelo Carmona-Rivera

  • STAT3 Mutations in the Hyper-IgE Syndrome

    Steven M. Holland;Frank R. DeLeo;Houda Z. Elloumi;Amy P. Hsu

  • Current concepts: immunology; neutrophils in human diseases

    Harry L. Malech;John I. Gallin

  • Genetic, biochemical, and clinical features of chronic granulomatous disease

    Brahm H. Segal;Thomas L. Leto;John I. Gallin;Harry L. Malech

  • Hyper-IgE Syndrome with Recurrent Infections — An Autosomal Dominant Multisystem Disorder

    Bodo Grimbacher;Steven M. Holland;John I. Gallin;Frank Greenberg

  • A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease

    J. I. Gallin;H. L. Malech;W. J. T. Curnutte;P. G. Quie

  • Residual NADPH oxidase and survival in chronic granulomatous disease.

    Douglas B. Kuhns;W. Gregory Alvord;Theo Heller;Jordan J. Feld

  • Flow cytometric analysis of the granulocyte respiratory burst: a comparison study of fluorescent probes.

    S.J. Vowells;S. Sekhsaria;H.L. Malech;M. Shalit

  • Gastrointestinal involvement in chronic granulomatous disease.

    Beatriz E Marciano;Sergio D Rosenzweig;David E Kleiner;Victoria L Anderson

  • Cytochrome b558: the flavin-binding component of the phagocyte NADPH oxidase

    Daniel Rotrosen;Choh L. Yeung;Thomas L. Leto;Harry L. Malech

  • The gene for familial Mediterranean fever, MEFV, is expressed in early leukocyte development and is regulated in response to inflammatory mediators

    Michael Centola;Geryl Wood;David M. Frucht;Jerome Galon

  • Fungal infection in chronic granulomatous disease. The importance of the phagocyte in defense against fungi.

    Myron S. Cohen;Raul E. Isturiz;Harry L. Malech;Richard K. Root

  • Itraconazole to prevent fungal infections in chronic granulomatous disease.

    John I Gallin;David W Alling;Harry L Malech;Robert Wesley

  • Genetic Linkage of Hyper-IgE Syndrome to Chromosome 4

    Bodo Grimbacher;Alejandro A. Schäffer;Steven M. Holland;Joie Davis

  • Cloning of a 67-kD neutrophil oxidase factor with similarity to a noncatalytic region of p60c-src.

    Thomas L. Leto;Karen J. Lomax;Bryan D. Volpp;Hiroyuki Nunoi

  • Differentiation of human and murine induced pluripotent stem cells to microglia-like cells.

    Hetal Pandya;Michael J Shen;David M Ichikawa;Andrea B Sedlock

  • Recombinant 47-kilodalton cytosol factor restores NADPH oxidase in chronic granulomatous disease

    Karen J. Lomax;Thomas L. Leto;Hiroyuki Nunoi;John I. Gallin

  • Two Forms of Autosomal Chronic Granulomatous Disease Lack Distinct Neutrophil Cytosol Factors

    Hiroyuki Nunoi;Daniel Rotrosen;John I. Gallin;Harry L. Malech

  • Common Severe Infections in Chronic Granulomatous Disease

    Beatriz E. Marciano;Christine Spalding;Alan Fitzgerald;Daphne Mann

  • Antibodies directed against synthetic peptides distinguish between GTP-binding proteins in neutrophil and brain.

    P Goldsmith;P Gierschik;G Milligan;C G Unson

  • Prolonged production of NADPH oxidase-corrected granulocytes after gene therapy of chronic granulomatous disease

    Harry L. Malech;Phillip B. Maples;Narda Whiting-Theobald;Gilda F. Linton

Frequent Co-Authors

John I. Gallin
John I. Gallin National Institutes of Health
Steven M. Holland
Steven M. Holland National Institute of Allergy and Infectious Diseases
Douglas B. Kuhns
Douglas B. Kuhns National Institutes of Health
Steven M. Holland
Steven M. Holland University of Georgia
Jennifer M. Puck
Jennifer M. Puck University of California, San Francisco
Theo Heller
Theo Heller National Institutes of Health
Thomas L. Leto
Thomas L. Leto National Institutes of Health
Thomas A. Fleisher
Thomas A. Fleisher National Institutes of Health
Morton J. Cowan
Morton J. Cowan University of California, San Francisco
Philip M. Murphy
Philip M. Murphy National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in immunology often intersects with various healthcare roles, making related online degrees valuable options for students. For those interested in nursing careers, accelerated programs can provide a quicker transition. Exploring accelerated fnp programs offers a fast track to becoming a Family Nurse Practitioner, blending advanced clinical skills with immunology knowledge.

Beginners without prior nursing experience can start with online bsn programs for non nurses, which provide flexible pathways into the nursing profession and foundational immunology concepts. Finding the right program matters, and understanding which are more accessible is key. For example, reviewing the easiest absn program to get into can help prospective students select a program that balances quality and admission feasibility.

For those seeking entry-level credentials, fastest and easiest lpn programs offer a practical route to enter healthcare roles supporting immunology research and clinical practice. These programs emphasize essential patient care skills that underpin understanding immune system health. By leveraging these related online degrees and career pathways, students can strategically align their education with careers that impact immunology and public health.

Best Scientists Citing Harry L. Malech

Trending Scientists

Recently Published Articles